Related Experiment Video
Updated: Jun 9, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
[Diagnosis and classification of pulmonary hypertension]
1Université Paris-Sud XI, Faculté de Médecine, 94276 Le Kremlin-Bicêtre, France.
Abstract:
Pulmonary hypertension (PH) has been defined as an increase in mean pulmonary arterial pressure (mPAP) > or = 25 mmHg at rest as assessed by right heart catheterisation (RHC). Precapillary pulmonary hypertension is defined by an increase in mPAP > or =25 mmHg and a pulmonary capillary wedge pressure (PCWP)< or =15 mmHg associated with a normal or reduced cardiac output. No definition for PH on exercise as assessed by RHC can be provided at the present time. In group 1 pulmonary arterial hypertension (PAH), the term "familial PAH" has been replaced by "heritable PAH". Heritable forms of PAH include clinically sporadic idiopathic PAH with germline mutations and clinical familial cases with or without identified germline mutations. Schistosomiasis and chronic haemolytic anaemia have been included among the group of associated PAH. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis have been individualized and designated as clinical group 1'.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure IV: Classification and Diagnostic Evaluation
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
